US Stock MarketDetailed Quotes
FOLD Amicus Therapeutics
- 9.630
- -0.140-1.43%
Close Dec 27 16:00 ET
- 9.600
- -0.030-0.31%
Post 17:11 ET
2.88BMarket Cap-28.32P/E (TTM)
9.790High9.550Low1.65MVolume9.690Open9.770Pre Close15.90MTurnover0.67%Turnover RatioLossP/E (Static)298.81MShares14.53052wk High16.10P/B2.36BFloat Cap9.02052wk Low--Dividend TTM245.30MShs Float25.390Historical High--Div YieldTTM2.46%Amplitude1.765Historical Low9.630Avg Price1Lot Size
Amicus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 40.10%-22.97M | 240.65%22.69M | -64.34%-29.7M | 58.52%-69.09M | 104.28%3.46M | -229.84%-38.35M | -1.71%-16.13M | 69.01%-18.07M | 17.74%-166.58M | -14.55%-80.77M |
| Net income from continuing operations | 68.81%-6.73M | 63.69%-15.7M | 8.53%-48.42M | 35.92%-151.58M | 39.42%-33.84M | 35.18%-21.58M | 30.45%-43.23M | 37.92%-52.93M | 5.55%-236.57M | 32.92%-55.87M |
| Operating gains losses | 199.88%5.78M | -57.52%7.66M | -70.50%1.74M | 448.05%33.55M | 368.42%15.43M | -333.66%-5.78M | 5,730.94%18.02M | 774.44%5.89M | 60.15%6.12M | 582.84%3.29M |
| Depreciation and amortization | -2.60%2.17M | -1.09%2.18M | 71.36%2.15M | 47.38%7.87M | 66.44%2.18M | 73.25%2.23M | 65.37%2.21M | -10.91%1.26M | -13.96%5.34M | -13.64%1.31M |
| Deferred tax | --0 | --0 | --0 | -54,977.78%-4.94M | --0 | --0 | --0 | ---4.94M | -73.53%9K | --9K |
| Other non cash items | -63.46%1.1M | 126.03%1.26M | 591.61%6.35M | -535.02%-16.15M | -775.57%-15.23M | 144.21%3.02M | -727.17%-4.85M | 266.61%918K | 375.17%3.71M | 128.25%2.26M |
| Change In working capital | -34.32%-43.98M | 328.47%11.09M | -608.06%-22.32M | 33.19%-26.64M | 127.49%14.11M | -951.45%-32.74M | -118.39%-4.86M | 73.41%-3.15M | -114.58%-39.88M | -959.85%-51.31M |
| -Change in receivables | 23.64%-8.64M | -345.68%-10M | 799.12%9.56M | -16.03%-20.11M | -16.05%-11.49M | -277.05%-11.32M | 218.93%4.07M | -36.70%-1.37M | -111.63%-17.33M | -445.07%-9.9M |
| -Change in inventory | -135.46%-34.73M | -3.69%-25.22M | 46.87%-1.68M | -735.00%-44.61M | 76.78%-2.38M | -1,171.95%-14.75M | -1,510.14%-24.33M | -274.28%-3.16M | 31.41%-5.34M | -115.10%-10.26M |
| -Change in prepaid assets | 203.71%14.26M | 236.85%19.3M | -390.38%-5.34M | -30.16%-8.06M | 3,037.48%17.95M | -1,147.46%-13.75M | -80.49%-14.1M | -44.81%1.84M | -4.65%-6.19M | 95.93%-611K |
| -Change in payables and accrued expense | -248.97%-14.12M | -14.41%27.12M | -33,904.17%-24.48M | 871.44%49.2M | 125.42%8.09M | 239.33%9.48M | -14.88%31.69M | 99.51%-72K | -185.83%-6.38M | -207.95%-31.84M |
| -Change in other working capital | 69.38%-737K | 95.26%-104K | 5.08%-374K | 34.12%-3.05M | 48.47%1.94M | 24.31%-2.41M | -65.31%-2.19M | 72.56%-394K | -12.61%-4.64M | 167.08%1.31M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 40.10%-22.97M | 240.65%22.69M | -64.34%-29.7M | 58.52%-69.09M | 104.28%3.46M | -229.84%-38.35M | -1.71%-16.13M | 69.01%-18.07M | 17.74%-166.58M | -14.55%-80.77M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4.17%34.27M | -143.95%-21.98M | -79.21%7.54M | 6.23%98.06M | 64.08%-23.96M | -52.00%35.77M | 90.18%50M | -37.72%36.26M | 17.21%92.32M | 2.03%-66.7M |
| Capital expenditure reported | 77.25%-356K | 50.14%-1.1M | 6.75%-1.81M | -97.56%-7.44M | 35.34%-1.73M | -1,242.34%-1.57M | -520.28%-2.2M | -122.96%-1.94M | 3.04%-3.77M | -52.10%-2.68M |
| Net investment purchase and sale | -7.24%34.63M | -140.00%-20.88M | -75.53%9.35M | 13.85%105.5M | 67.04%-22.23M | -49.81%37.33M | 95.91%52.2M | -35.35%38.2M | 12.13%92.67M | -1.67%-67.44M |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.41M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4.17%34.27M | -143.95%-21.98M | -79.21%7.54M | 6.23%98.06M | 64.08%-23.96M | -52.00%35.77M | 90.18%50M | -37.72%36.26M | 17.21%92.32M | 2.03%-66.7M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -51.65%18.19M | -103.62%-857K | -70.08%-13.31M | 926.44%61.68M | 1,373.97%8.21M | 6,829.70%37.62M | 3,316.02%23.67M | 4.03%-7.83M | -103.52%-7.46M | 635.58%557K |
| Net issuance payments of debt | 177.42%24K | -56.52%-36K | -50.00%-42K | -7,305.65%-20.96M | -10,829.84%-20.88M | 39.22%-31K | -9.52%-23K | -40.00%-28K | 40.92%-283K | -905.26%-191K |
| Net common stock issuance | -47.60%19.15M | --0 | --0 | --92.94M | --29.83M | --36.56M | --24.2M | --2.35M | --0 | --0 |
| Proceeds from stock option exercised by employees | -47.56%1.81M | -51.02%863K | 30.09%3.45M | 138.35%10.27M | 115.73%2.41M | 158.21%3.44M | 76.38%1.76M | 209.08%2.66M | -85.37%4.31M | -40.19%1.12M |
| Net other financing activities | -18.96%-2.79M | 25.65%-1.68M | -30.57%-16.72M | -79.05%-20.57M | -750.40%-3.16M | -27.49%-2.35M | -694.74%-2.27M | -42.40%-12.81M | 31.02%-11.49M | 81.03%-371K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -51.65%18.19M | -103.62%-857K | -70.08%-13.31M | 926.44%61.68M | 1,373.97%8.21M | 6,829.70%37.62M | 3,316.02%23.67M | 4.03%-7.83M | -103.52%-7.46M | 635.58%557K |
| Net cash flow | ||||||||||
| Beginning cash position | -0.92%212.36M | 28.98%212.79M | 63.33%250.08M | -38.62%153.12M | -5.42%266.27M | -10.64%214.33M | -30.63%164.98M | -38.62%153.12M | 50.13%249.46M | -27.64%281.53M |
| Current changes in cash | -15.83%29.49M | -100.25%-143K | -442.31%-35.47M | 210.92%90.65M | 91.64%-12.29M | -43.79%35.04M | 417.32%57.54M | 225.50%10.36M | -192.51%-81.72M | -5.92%-146.92M |
| Effect of exchange rate changes | -129.75%-5.03M | 96.41%-294K | -220.50%-1.82M | 143.18%6.31M | -121.11%-3.91M | 181.82%16.9M | 9.84%-8.19M | 144.63%1.51M | -189.54%-14.62M | 2,137.56%18.5M |
| End cash Position | -11.06%236.82M | -0.92%212.36M | 28.98%212.79M | 63.33%250.08M | 63.33%250.08M | -5.42%266.27M | -10.64%214.33M | -30.63%164.98M | -38.62%153.12M | -38.62%153.12M |
| Free cash flow | 41.55%-23.33M | 217.77%21.59M | -57.44%-31.51M | 55.07%-76.53M | 102.07%1.73M | -247.39%-39.91M | -13.06%-18.34M | 66.19%-20.01M | 17.46%-170.34M | -15.46%-83.45M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data